×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 9, Part II – Real World Evidence: Safety Applications
Session Chair(s)
Stephen Knowles, MD, MRCP
Chief Medical Officer
Halozyme Therapeutics, United States
Session 9, Part II – Real World Evidence: Safety Applications
Speaker(s)
Current Use of Real World Evidence of Signal Assessment
John Seeger, DrPH, PharmD
Harvard Medical School/Brigham & Women's Hospital, United States
Assistant Professor
Future of Large Databases in Data Mining
Andrew Bate, PhD, MA
GlaxoSmithKline, United Kingdom
Vice President, Head of Safety Innovation and Analytics
Assessing the Effectiveness of Risk Minimization Programs: Future Needs and Opportunities for Using Real World Evidence
Gary H. Slatko, MD
FDA , United States
Director, Office of Medication Error Prevention and Risk Management, OSE, CDER
Have an account?